Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription 08.07.2019 1 AIDS Res Hum Retroviruses 5 BMJ 2 Clin Infect Dis 3 J Infect Dis 2 J Virol 2 JAMA 2 Lancet 6 Lancet Infect Dis 1 Nat Med 3 Pediatr Infect Dis J 2 PLoS Med 5 PLoS One 1 Science 22 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS Res Hum Retroviruses

1. MCCLUSKEY MM
   Bonnie Mathieson (1945-2018).
   AIDS Res Hum Retroviruses. 2018;34:237-238.
   PubMed     Text format    
   
   

   
   BMJ

2. SO M
   Compulsory vaccination: encourage trust before resorting to mandates.
   BMJ. 2019;366:l4471.
   PubMed     Text format    
   
   
3. TORJESEN I
   HPV vaccine: high coverage could eradicate cervical cancer within decades, say researchers.
   BMJ. 2019;365:l4450.
   PubMed     Text format    
   
   
4. VETRUGNO G, Cicconi M, Foti F, Spagnolo A, et al
   Compulsory vaccination would exacerbate resistance.
   BMJ. 2019;366:l4464.
   PubMed     Text format    
   
   
5. TEMPLE M
   Compulsory vaccination: case isolation is likely to be more effective.
   BMJ. 2019;366:l4472.
   PubMed     Text format    
   
   
6. BROADBENT JJ
   Vaccine hesitancy: misinformation on social media.
   BMJ. 2019;366:l4457.
   PubMed     Text format    
   
   

   
   Clin Infect Dis

7. KLEIN NP, Fireman B
   If Influenza Vaccines Wane Can We Delay Vaccination Without Compromising Coverage?
   Clin Infect Dis. 2019 Jun 29. pii: 5525380. doi: 10.1093.
   PubMed     Text format    
   
   
8. FERDINANDS JM, Alyanak E, Reed C, Fry AM, et al
   Waning of influenza vaccine protection: Exploring the trade-offs of changes in vaccination timing among older adults.
   Clin Infect Dis. 2019 Jun 29. pii: 5525379. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

9. WILSON P, Parr JB, Jhaveri R, Meshnick SR, et al
   Call to action: Prevention of mother-to-child transmission of hepatitis B in Africa.
   J Infect Dis. 2018 Jan 17. pii: 4812591. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
10. JAGGER BW, Dowd KA, Chen RE, Desai P, et al
    Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice.
    J Infect Dis. 2019 Jul 1. pii: 5526737. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
11. LARTEY S, Zhou F, Brokstad KA, Mohn KG, et al
    Live attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction.
    J Infect Dis. 2019 Jun 27. pii: 5524503. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

12. LI X, Gao Y, Ye Z
    A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    J Virol. 2019 Jul 3. pii: JVI.00570-19. doi: 10.1128/JVI.00570.
    PubMed     Text format     Abstract available
    
    
13. CARRAU L, Rezelj VV, Noval MG, Levi LI, et al
    Chikungunya virus vaccine candidates with decreased mutational robustness are attenuated in vivo and have compromised transmissibility.
    J Virol. 2019 Jul 3. pii: JVI.00775-19. doi: 10.1128/JVI.00775.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

14. PINGALI SC, Delamater PL, Buttenheim AM, Salmon DA, et al
    Associations of Statewide Legislative and Administrative Interventions With Vaccination Status Among Kindergartners in California.
    JAMA. 2019;322:49-56.
    PubMed     Text format     Abstract available
    
    
15. DAVIS MM, Shah SK
    Outbreaks of Vaccine-Preventable Diseases: Responding to System Failure With National Vaccination Requirements.
    JAMA. 2019;322:33-34.
    PubMed     Text format    
    
    

    
    Lancet

16. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    PubMed     Text format     Abstract available
    
    
17. DE SANJOSE S, Delany-Moretlwe S
    HPV vaccines can be the hallmark of cancer prevention.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30549.
    PubMed     Text format    
    
    

    
    Lancet Infect Dis

18. HATCHETT R, Lurie N
    Outbreak response as an essential component of vaccine development.
    Lancet Infect Dis. 2019 Jun 27. pii: S1473-3099(19)30305.
    PubMed     Text format     Abstract available
    
    
19. ABUBAKAR I, Drobniewski F, Southern J, Sitch AJ, et al
    Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.
    Lancet Infect Dis. 2018 Aug 30. pii: S1473-3099(18)30355.
    PubMed     Text format     Abstract available
    
    
20. OLESEN OF, Abdullah F, Coppens R, Gardner PJ, et al
    New hope for tuberculosis vaccines.
    Lancet Infect Dis. 2019;19:687-688.
    PubMed     Text format    
    
    
21. GESSNER BD, Sings HL, Jodar L
    Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines.
    Lancet Infect Dis. 2019;19:692-693.
    PubMed     Text format    
    
    
22. GOLDBLATT D, Madhi SA
    Efficacy and effectiveness of ten-valent versus 13-valent pneumococcal conjugate vaccines - Authors' reply.
    Lancet Infect Dis. 2019;19:693-694.
    PubMed     Text format    
    
    
23. CORDONNIER C, Mikulska M, Einarsdottir S, Cesaro S, et al
    2017 ECIL 7 vaccine guidelines.
    Lancet Infect Dis. 2019;19:694-695.
    PubMed     Text format    
    
    

    
    Nat Med

24. 
    Time to vaccinate against hesitancy.
    Nat Med. 2019 Jul 3. pii: 10.1038/s41591-019-0524.
    PubMed     Text format    
    
    

    
    Pediatr Infect Dis J

25. WILCOX CR, Calvert A, Metz J, Kilich E, et al
    Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study.
    Pediatr Infect Dis J. 2019 Jun 20. doi: 10.1097/INF.0000000000002384.
    PubMed     Text format     Abstract available
    
    
26. HUBICHE T, Brazier C, Vabret A, Reynaud S, et al
    MEASLES TRANSMISSION IN A FULLY VACCINATED CLOSED COHORT: Data From a Nosocomial Clustered Cases in a Teenage Psychiatric Unit.
    Pediatr Infect Dis J. 2019 Jun 20. doi: 10.1097/INF.0000000000002372.
    PubMed     Text format     Abstract available
    
    
27. RIVERO I, Raguindin PF, Buttler R, Martinon-Torres F, et al
    False Vaccine Contraindications Among Healthcare Providers in Europe: A Short Survey Among Members of The European Society of Pediatric Infectious Diseases.
    Pediatr Infect Dis J. 2019 Jun 21. doi: 10.1097/INF.0000000000002401.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

28. CHOI YH, Andrews N, Miller E
    Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.
    PLoS Med. 2019;16:e1002845.
    PubMed     Text format     Abstract available
    
    
29. BAKER MA, Baer B, Kulldorff M, Zichittella L, et al
    Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results.
    PLoS Med. 2019;16:e1002844.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

30. GUPALOVA T, Leontieva G, Kramskaya T, Grabovskaya K, et al
    Development of experimental pneumococcal vaccine for mucosal immunization.
    PLoS One. 2019;14:e0218679.
    PubMed     Text format     Abstract available
    
    
31. 
    Retraction: Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    PLoS One. 2019;14:e0218050.
    PubMed     Text format    
    
    
32. WU HH, Chang YY, Kuo SC, Chen YT, et al
    Influenza vaccination and secondary prevention of cardiovascular disease among Taiwanese elders-A propensity score-matched follow-up study.
    PLoS One. 2019;14:e0219172.
    PubMed     Text format     Abstract available
    
    
33. OBIRI-YEBOAH D, Awuku YA, Adjei G, Cudjoe O, et al
    Post Hepatitis B vaccination sero-conversion among health care workers in the Cape Coast Metropolis of Ghana.
    PLoS One. 2019;14:e0219148.
    PubMed     Text format     Abstract available
    
    
34. STENZEL T, Dziewulska D, Smialek M, Tykalowski B, et al
    Comparison of the immune response to vaccination with pigeon circovirus recombinant capsid protein (PiCV rCP) in pigeons uninfected and subclinically infected with PiCV.
    PLoS One. 2019;14:e0219175.
    PubMed     Text format     Abstract available
    
    

    
    Science

35. KUPFERSCHMIDT K
    Plan to use second Ebola vaccine sparks debate.
    Science. 2019;364:1221.
    PubMed     Text format    
    
    

    
    Vaccine

36. RENSON P, Fablet C, Andraud M, Normand V, et al
    Maternally-derived neutralizing antibodies reduce vaccine efficacy against porcine reproductive and respiratory syndrome virus infection.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30807.
    PubMed     Text format     Abstract available
    
    
37. TSHILWANE SI, Thema N, Steyn HC, van Kleef M, et al
    A multi-epitope DNA vaccine co-administered with monophosphoryl lipid A adjuvant provides protection against tick transmitted Ehrlichia ruminantium in sheep.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30788.
    PubMed     Text format     Abstract available
    
    
38. HAUSER MI, Muscatello DJ, Soh ACY, Dwyer DE, et al
    An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30801.
    PubMed     Text format     Abstract available
    
    
39. SOBEY KG, Jamieson SE, Walpole AA, Rosatte RC, et al
    ONRAB(R) oral rabies vaccine is shed from, but does not persist in, captive mammals.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30808.
    PubMed     Text format     Abstract available
    
    
40. HEWITT JS, Karuppannan AK, Tan S, Gauger P, et al
    A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30806.
    PubMed     Text format     Abstract available
    
    
41. RUSS SM, Brackney M, Meek J, Niccolai LM, et al
    Missed Opportunities for HPV Vaccination Among Vaccine-Eligible Women with High Grade Cervical Lesions.
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30836.
    PubMed     Text format     Abstract available
    
    
42. CONSTABLE C, Chapman CR
    Bolstering trust in the human papillomavirus vaccine through improved communication in the vaccine information statement.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30766.
    PubMed     Text format    
    
    
43. KNEZEVIC I
    1st WHO International Standard antiserum to RSV: Availability and benefits for RSV vaccine development (Commentary on the collaborative study report published in the vaccine journal (Vaccine 2018 36: 7641-7649)).
    Vaccine. 2019 Jun 24. pii: S0264-410X(19)30783.
    PubMed     Text format    
    
    
44. BRUUN T, Watle SSV, Tveteraas IH, Flem E, et al
    Intussusception among Norwegian children: What to expect after introduction of rotavirus vaccination?
    Vaccine. 2019 Jun 26. pii: S0264-410X(19)30820.
    PubMed     Text format     Abstract available
    
    
45. ANDREWS N, Kent A, Amin-Chowdhury Z, Sheppard C, et al
    Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
    Vaccine. 2019 Jul 1. pii: S0264-410X(19)30848.
    PubMed     Text format     Abstract available
    
    
46. OZGEN MH, Blume S
    The continuing search for an addiction vaccine.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30851.
    PubMed     Text format     Abstract available
    
    
47. ADRIEN N, Hyde TB, Gacic-Dobo M, Hombach J, et al
    Differences between coverage of yellow fever vaccine and the first dose of measles-containing vaccine: A desk review of global data sources.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30838.
    PubMed     Text format     Abstract available
    
    
48. DABANCH J, Gonzalez C, Cerda J, Acevedo J, et al
    Chile's National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30846.
    PubMed     Text format     Abstract available
    
    
49. D'OFFAY JM, Fulton RW, Fishbein M, Eberle R, et al
    Isolation of a naturally occurring vaccine/wild-type recombinant bovine herpesvirus type 1 (BoHV-1) from an aborted bovine fetus.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30821.
    PubMed     Text format     Abstract available
    
    
50. VAN AALST R, Russo EM, Neupane N, Mahmud SM, et al
    Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30843.
    PubMed     Text format     Abstract available
    
    
51. PEYRAUD N, Zehrung D, Jarrahian C, Frivold C, et al
    Potential use of microarray patches for vaccine delivery in low- and middle- income countries.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30357.
    PubMed     Text format     Abstract available
    
    
52. DURO TORRIJOS JL, Tuells J
    The beginnings of smallpox vaccination in Spain seen through the correspondence of Ignacio Maria Ruiz de Luzuriaga (1801-1802).
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30735.
    PubMed     Text format     Abstract available
    
    
53. YU XY, Chen ZP, Wang SY, Pan HR, et al
    Safety and immunogenicity of hepatitis E vaccine in elderly people older than 65years.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30444.
    PubMed     Text format     Abstract available
    
    
54. BRYDEN GM, Browne M, Rockloff M, Unsworth C, et al
    The privilege paradox: Geographic areas with highest socio-economic advantage have the lowest rates of vaccination.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30822.
    PubMed     Text format     Abstract available
    
    
55. VOM STEEG LG, Flores-Garcia Y, Zavala F, Klein SL, et al
    Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30852.
    PubMed     Text format     Abstract available
    
    
56. ALMUDEVAR A, Kaur R, Pichichero M
    Statistical projection of post-vaccination antibody kinetics between dosing schedules.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30778.
    PubMed     Text format     Abstract available
    
    
57. TANIGUCHI M, Ueda Y, Yagi A, Ikeda S, et al
    Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
    Vaccine. 2019 Jul 1. pii: S0264-410X(19)30839.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: